LEADER 00814nam0 2200265   450 
001 000007074
005 20090325134238.0
100   $a20060413d2005----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $ay-------001yy
200 1 $aEconomic growth$fDavid N. Weil
210   $aBoston$cPearson Addison Wesley$d2005
215   $a547 p.$d24 cm
225 2 $aThe Addison-Wesley series in economics
410  0$12001$aThe Addison-Wesley series in economics
500 10$aEconomic growth$924248
610 1 $aTeoria e modelli dello sviluppo economico
676   $a330$v21$9Economia
700  1$aWeil,$bDavid N.$0312236
801  0$aIT$bUNIPARTHENOPE$c20090325$gRICA$2UNIMARC
912   $a000007074
951   $a112/138$b10653$cNAVA2$d2006
996   $aEconomic growth$924248
997   $aUNIPARTHENOPE

LEADER 01335oam  2200397 a 450 
001 9910693982903321
005 20050307151024.0
035   $a(CKB)4970000000046696
035   $a(OCoLC)53364473
035 9 $aocm53364473
035   $a(OCoLC)994970000000046696
035   $a(EXLCZ)994970000000046696
100   $a20031106d2002      ua             0
101 0 $aeng
135   $aurbn||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrescription drugs$b[electronic resource] $estate monitoring programs provide useful tool to reduce diversion /$fUnited States General Accounting Office
210  1$aWashington, D.C. :$cU.S. General Accounting Office,$d[2002]
300   $aTitle from title screen (viewed Nov. 06, 2003).
300   $aPaper version available from: U.S. General Accounting Office, 441 G st, NW, Rm. LM, Washington, D.C. 20548.
300   $a"May 2002."
300   $a"GAO-02-634."
320   $aIncludes bibliographical references.
517   $aPrescription Drugs
606   $aDrug abuse$zUnited States$xPrevention
615  0$aDrug abuse$xPrevention.
801  0$bGPO
801  1$bGPO
801  2$bOCLCQ
801  2$bGPO
906   $aDOCUMENT
912   $a9910693982903321
996   $aPrescription drugs$92884258
997   $aUNINA